Corvus Pharmaceuticals, Inc. (CRVS) Seems To Be Turning Some Investors Off

Corvus Pharmaceuticals, Inc. (CRVS) has seen some recent volatility in the stock market and its stock closed at $3.8000 yesterday. People are starting to take notice of CRVS as the stock traded as high as $4.0200 and as low as $3.7900 in the last market trading session.

Corvus Pharmaceuticals, Inc. (CRVS) average trading volume is 926.45K. However, in the last market trading session Corvus Pharmaceuticals, Inc. (CRVS) traded 413,235 shares. The First support level on CRVS is $3.77 and the First resistance level on CRVS is $5.74. CRVS 50day moving average is $4.0733 and CRVS 200day moving average is $3.6334.

Corvus Pharmaceuticals, Inc. (CRVS) recent performance has been shown by the recent movement in CRVS stock. CRVS has performed -3.31% over the past 30 days, CRVS has performed -11.01% over the past 90 days and CRVS has shown 7.34% over the past 365 days. Corvus Pharmaceuticals, Inc. (CRVS) has a 1 year range of $1.0100 to $6.8800. Corvus Pharmaceuticals, Inc. (CRVS) is trading 276.24% from its 1 year low and -44.77% from its 1 year high. Corvus Pharmaceuticals, Inc. (CRVS) is showing a 5.87% short float showing the quantity short in the float.

CRVS has 29.43M shares outstanding and 23.36M shares in the float. Corvus Pharmaceuticals, Inc. (CRVS) presently has a market cap of $107.58M and income of -45.60M. The EPS next quarter for CRVS is -0.24 and projected EPS next year is -22.20%. The market cap of Corvus Pharmaceuticals, Inc. (CRVS) at $107.58M represents how many People own shares of CRVS and is based off the last price ($3.8000) of CRVS and the quantity of shares outstanding (29.43M) with Corvus Pharmaceuticals, Inc. (CRVS).

Corvus Pharmaceuticals, Inc. (CRVS) has aggregate cash (mrq) of 59.26M, aggregate cash per share (mrq) of 2.11, aggregate debt of CRVS rests at 2.76M and aggregate debt/equity (mrq) is 5.43. . Corvus Pharmaceuticals, Inc. (CRVS) operational cash flow (ttm) is -37.96M, CRVS leveraged free cash flow (ttm) is -21.24M.

CRVS is trading -6.97% below (bearish) its SMA20, -3.88% below (bearish) its SMA50 and 3.74% above (bullish) its SMA200.

Related Articles

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Fuwei (NASDAQ: FFHL) Plans To Sell Dornier Production Line

Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) recently declared that it will be closing its Dornier line of production as early as possible. Fuwei...

PPG Industries (NYSE: PPG) Announces Accquisition Of Ennis-Flint

PPG Industries, Inc. (NYSE: PPG) is planning to buy Ennis-Flint in a deal valued at nearly $1.15 billion. The decision to acquire Ennis-Flint will...